Breaking News

FUJIFILM Biosciences Introduces BalanCD HEK293 Perfusion A Medium 

Designed to further enable process optimization by maximizing cell growth, viability, and productivity for a wide range of applications.

FUJIFILM Biosciences, has launched BalanCD HEK293 Perfusion A gene therapy application solution. BalanCD HEK293 Perfusion A uses suspension HEK293 cells and perfusion technology to provide reliable, efficient, and scalable production of viral vectors for development of gene therapies, according to the company. HEK293 cells are well established for gene therapy applications in upstream bioprocessing, offering reliable growth rates, high transfection success and expression of cellular factors n...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters